Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Kenji Yanishi"'
Autor:
Daiki Goto, Kenji Yanishi, Takaaki Ozawa, Jun Yoshimura, Hirofumi Kawamata, Ayumu Fujioka, Tomotsugu Seki, Kan Zen, Satoaki Matoba
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 12 (2024)
Background Acute mesenteric ischemia is rare, and few large‐scale trials have evaluated endovascular therapy (EVT) and open surgical revascularization (OS). This study aimed to assess clinical outcomes after EVT or OS for acute superior mesenteric
Externí odkaz:
https://doaj.org/article/c3d165435b5b4caa80ff228f29caf00b
Publikováno v:
BMJ Health & Care Informatics, Vol 31, Iss 1 (2024)
Background The detrimental repercussions of the COVID-19 pandemic on the quality of care and clinical outcomes for patients with acute coronary syndrome (ACS) necessitate a rigorous re-evaluation of prognostic prediction models in the context of the
Externí odkaz:
https://doaj.org/article/9447f95ae32b46c7b68fb31ebbe2fa79
Autor:
Masao Takigami, Naohiko Nakanishi, Hideo Tsubata, Kuniyoshi Fukai, Yuki Matsubara, Kenji Yanishi, Kan Zen, Takeshi Nakamura, Satoaki Matoba
Publikováno v:
PLoS ONE, Vol 18, Iss 1, p e0280683 (2023)
BackgroundBalloon pulmonary angioplasty (BPA) is used for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH) and residual pulmonary hypertension after pulmonary endarterectomy (PEA) to improve hemodynamics, right ventricula
Externí odkaz:
https://doaj.org/article/76f56232e39745568c9c6a5e08198c18
Autor:
Yusuke Hori, Tomoya Kitani, Kenji Yanishi, Takaomi Suga, Masaya Kogure, Tetsuro Kusaba, Yoshihiro Kushida, Mari Dezawa, Satoaki Matoba
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Cell-based therapies hold great promise for the treatment of peripheral arterial disease (PAD), especially in patients presenting with severe limb ischemia, although the optimal strategy remains to be explored. In this study, we evaluated the therape
Externí odkaz:
https://doaj.org/article/f7c2a9285b4a4fdd93fea74dd1b056c6
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-6 (2021)
Abstract Background While developments in oncology have lengthened survival in patients with cancer, such patients often develop cardiovascular diseases. Thus, percutaneous coronary intervention (PCI) is frequently undertaken in them. Although stent
Externí odkaz:
https://doaj.org/article/a167d72b0f214a70ace60696d9a220d2
Autor:
Keisuke Shoji, Kenji Yanishi, Noriyuki Wakana, Naohiko Nakanishi, Kan Zen, Takeshi Nakamura, Takeshi Shirayama, Satoaki Matoba
Publikováno v:
Journal of Medical Case Reports, Vol 14, Iss 1, Pp 1-7 (2020)
Abstract Background Hyperhomocysteinemia is caused by genetic and environmental factors, which can result in systemic arteriosclerosis and arteriovenous thrombosis including acute coronary syndrome. Thrombus burden in patients with acute coronary syn
Externí odkaz:
https://doaj.org/article/adb94688e139463d80089e62d73cb219
Autor:
Keisuke Shoji, Kan Zen, Kenji Yanishi, Noriyuki Wakana, Naohiko Nakanishi, Takeshi Nakamura, Satoaki Matoba
Publikováno v:
CVIR Endovascular, Vol 3, Iss 1, Pp 1-5 (2020)
Abstract Background Acute limb ischemia (ALI) and critical limb ischemia (CLI) following ALI are life-threatening diseases. The rare potential causes of ALI include hypercoagulable state diseases, such as antiphospholipid syndrome (APS) and essential
Externí odkaz:
https://doaj.org/article/5e91a359beea4ee5b670a4723eeb51d3
Autor:
Masao Takigami, Hideo Tsubata, Naohiko Nakanishi, Yuki Matsubara, Noriyuki Wakana, Kenji Yanishi, Kan Zen, Takeshi Nakamura, Satoaki Matoba
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0263244 (2022)
BackgroundBalloon pulmonary angioplasty (BPA) is an effective treatment for inoperable chronic thromboembolic pulmonary hypertension (CTEPH). The purpose of this study is to evaluate the therapeutic effect and safety of the non-slip element percutane
Externí odkaz:
https://doaj.org/article/44d24756c87843c4be2088e58047eeed
Autor:
Keisuke Shoji, Kenji Yanishi, Hirokazu Shiraishi, Shiho Yamabata, Arito Yukawa, Satoshi Teramukai, Kojiro Imai, Toshiko Ito-Ihara, Masami Tao, Yukihito Higashi, Tomoaki Ishigami, Yoshihiro Fukumoto, Koichiro Kuwahara, Satoaki Matoba
Publikováno v:
Contemporary Clinical Trials Communications, Vol 17, Iss , Pp - (2020)
Critical limb ischemia (CLI) is a potentially life-threatening condition that involves severely reduced blood flow to the peripheral arteries due to arteriosclerosis obliterans (ASO) of the limbs or a similar condition. CLI patients must undergo reva
Externí odkaz:
https://doaj.org/article/e8d22b48e10447e283ee66badf5ba8bf
Autor:
Kenji Yanishi, Takeshi Nakamura, Naohiko Nakanishi, Isao Yokota, Kan Zen, Tetsuhiro Yamano, Hirokazu Shiraishi, Takeshi Shirayama, Jun Shiraishi, Takahisa Sawada, Yoshio Kohno, Makoto Kitamura, Keizo Furukawa, Satoaki Matoba
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0166391 (2016)
Many mortality risk scoring tools exist among patients with ST-elevation Myocardial Infarction (STEMI). A risk stratification model that evaluates STEMI prognosis more simply and rapidly is preferred in clinical practice.We developed a simple stratif
Externí odkaz:
https://doaj.org/article/342eb8e84d7f467ea1840b79d94876fd